Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “REGENERA PHARMA LTD.”

17 pharma patents match "REGENERA PHARMA LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 17
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 17 pharmaceutical patents matching "REGENERA PHARMA LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

17 results for “REGENERA PHARMA LTD.” · 30,257 patents in full index Clear search

  1. US 11207333

    Compositions comprising triterpenoids and uses thereof for treating optic neuropathy

    REGENERA PHARMA LTD. · Granted Dec 28, 2021 · Expires Dec 23, 2041

    granted
  2. US 11173164

    Compositions comprising triterpenoids

    REGENERA PHARMA LTD. · Granted Nov 16, 2021 · Expires Nov 11, 2041

    granted
  3. US 11083736

    Compositions comprising triterpenoids

    REGENERA PHARMA LTD. · Granted Aug 10, 2021 · Expires Aug 5, 2041

    granted
  4. US 11000562

    Use of isolated fractions of mastic gum for treating optic neuropathy

    REGENERA PHARMA LTD. · Granted May 11, 2021 · Expires May 6, 2041

    granted
  5. US 10806763

    Compositions of polymeric myrcene

    REGENERA PHARMA LTD. · Granted Oct 20, 2020 · Expires Oct 15, 2040

    granted
  6. US 10751347

    Compositions comprising acidic extracts of mastic gum and uses thereof for treating optic neuropathy

    REGENERA PHARMA LTD. · Granted Aug 25, 2020 · Expires Aug 20, 2040

    granted
  7. US 10588911

    Compositions comprising triterpenoids

    REGENERA PHARMA LTD. · Granted Mar 17, 2020 · Expires Mar 12, 2040

    granted
  8. US 10561670

    Compositions comprising acidic extracts of mastic gum

    REGENERA PHARMA LTD. · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted
  9. US 10307449

    Compositions of polymeric myrcene

    REGENERA PHARMA LTD. · Granted Jun 4, 2019 · Expires May 30, 2039

    granted
  10. US 10285996

    Compositions comprising triterpenoids

    REGENERA PHARMA LTD. · Granted May 14, 2019 · Expires May 9, 2039

    granted
  11. US 10251923

    Therapeutic uses of mastic gum fractions

    REGENERA PHARMA LTD. · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted
  12. US 10159680

    Compositions comprising acidic extracts of mastic gum

    REGENERA PHARMA LTD. · Granted Dec 25, 2018 · Expires Dec 20, 2038

    granted
  13. US 9770456

    Compositions comprising acidic extracts of mastic gum

    REGENERA PHARMA LTD. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  14. US 9655938

    Compositions of polymeric myrcene

    REGENERA PHARMA LTD. · Granted May 23, 2017 · Expires May 18, 2037

    granted
  15. US 9364509

    Therapeutic uses of mastic gum fractions

    REGENERA PHARMA LTD. · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  16. US 9271949

    Compositions comprising acidic extracts of mastic gum

    REGENERA PHARMA LTD. · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  17. US 8956601

    Therapeutic uses of mastic gum fractions

    REGENERA PHARMA LTD. · Granted Feb 17, 2015 · Expires Feb 12, 2035

    granted